Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

TNXPTNXP
6 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in TONIX PHARMACEUTICALS HLDG C

BANK OF AMERICA CORP /DE/ holds 60,977 shares of TNXP (TONIX PHARMACEUTICALS HLDG C), worth $778,067 as of 2026-Q2. The position was increased (+0.0% shares). TNXP represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$778,067

Current Shares

60,977

Total Value Change

+$675,107

Total Shares Change

+55,217

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
60,977
+0.0%
$778,0670.0%$12.76
25
2026-Q1
Increased
60,958
+101.1%
$838,1730.0%$13.94
40
2025-Q4
Increased
30,314
+551.8%
$473,5050.0%$15.82
26
2025-Q3
Increased
4,651
+32.7%
$112,3680.0%$24.76
19
2025-Q2
Decreased
3,505
-39.1%
$126,1100.0%$34.89
0
2025-Q1
New
5,760
-
$102,9600.0%$20.17
33

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used